November 2025
santhera.com
Global Rank
#3,151,450
1,678,092Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
51.7%
Pages per Visit
1.71
Avg Visit Duration
00:00:27
- Company
- Santhera
Top 10 santhera.com Competitors
The Top 10 Sites Like santhera.com in November 2025 are ranked by their affinity to santhera.com in terms of keyword traffic, audience targeting, and market overlap
learn how johnson & johnson innovative medicine is transforming the future of healthcare and leading where medicine is going.
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%we are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
- Company
- - -
- Industry
- - -
Global Rank
#2,742,916
30,612Total Visits
6.6K
Bounce Rate
32.94%
Pages per Visit
2.01
Avg Visit Duration
00:00:42
Similarity Score
99%Global Rank
#2,322,044
474,652Total Visits
9.8K
Bounce Rate
42.18%
Pages per Visit
1.45
Avg Visit Duration
00:00:08
Similarity Score
91%Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.
- Company
- Eisai
Global Rank
#590,537
20,801Total Visits
57.8K
Bounce Rate
42.6%
Pages per Visit
1.71
Avg Visit Duration
00:00:29
Similarity Score
83%Below, you will find pdf roadmaps to help you along your journey. Click the tile to open a single pdf, or check the box to download multiple pdfs at one time. Videos will open in a video player, so you can view them directly in your browser. You can navigate between the Education Series’ by…
- Company
- PTC Therapeutics
Global Rank
#1,160,429
311,325Total Visits
23.3K
Bounce Rate
40.29%
Pages per Visit
1.83
Avg Visit Duration
00:00:12
Similarity Score
83%Browse listings in Consulting | Industry news, events, directory, Swiss Biotech Association
- Company
- - -
- Industry
- - -
Global Rank
#555,901
12,197Total Visits
51.2K
Bounce Rate
44.79%
Pages per Visit
2.67
Avg Visit Duration
00:01:00
Similarity Score
79%Working together, we can reimagine medicine to improve and extend people’s lives.
- Company
- Novartis
Global Rank
#48,904
939Total Visits
1.1M
Bounce Rate
49.89%
Pages per Visit
2.86
Avg Visit Duration
00:01:39
Similarity Score
76%at deciphera, we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work.
- Company
- Deciphera
Global Rank
#1,733,850
85,603Total Visits
12.1K
Bounce Rate
33.26%
Pages per Visit
2.37
Avg Visit Duration
00:01:18
Similarity Score
75%The Investor Relations website contains information about PhaseBio Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Global Rank
- -
Country Rank
- -
Category Rank
- -
Total Visits
706
Bounce Rate
42.34%
Pages per Visit
2.16
Avg Visit Duration
00:00:53
Similarity Score
75%Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
74%santhera.com's top 5 competitors in November 2025 are: actelion.com, newron.com, basilea.com, eisai.com, and more.
According to Similarweb data of monthly visits, santhera.com’s top competitor in November 2025 is actelion.com with -- visits. santhera.com 2nd most similar site is newron.com, with 6.6K visits in November 2025, and closing off the top 3 is basilea.com with 9.8K.
eisai.com ranks as the 4th most similar website to santhera.com and ptcbio.com ranks fifth. eisai.com and ptcbio.com received 57.8K visits and 23.3K visits in November 2025, respectively.
The other five competitors in the top 10 list are swissbiotech.org (51.2K visits in November 2025), novartis.com (1.1M visits in November 2025), deciphera.com (12.1K visits in November 2025), phasebio.com (706 visits in November 2025), and adamaspharma.com (-- visits in November 2025).